Código QR (código de barras bidimensional)

Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry

Abstract Introduction Apixaban has been shown to be superior to warfarin in patients with non-valvular atrial fibrillation in the randomized ARISTOTLE trial and its use is recommended in current guidelines. There are only scarce data about its use, efficacy, and safety in unselected patients in Germ...

Fuld beskrivelse

Na minha lista:
Principais autores: Uwe Zeymer, Christiane Lober, Andreas Wolf, Frank Richard, Heinrich Schäfer, Jens Taggeselle, Hans-Joachim Kabitz, Roland Prondzinsky, Tim Süselbeck, the APAF-Investigators
Format: Artigo
Sprog:Inglês
Udgivet: Adis, Springer Healthcare 2020-07-01
Serier:Cardiology and Therapy
Fag:
Atrial fibrillation
Apixaban
Prospective registry
Persistence
Online adgang:https://doi.org/10.1007/s40119-020-00188-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker